The U.S. stocks set to benefit most from China’s ‘bazooka’ stimulus, according to Barclays

A major stimulus deal coming out of China could offer a windfall for some U.S. stocks with significant ties to the world’s second-largest economy, according to Barclays. “While not Barclays’ base case, a China bazooka stimulus would have far-reaching effects on global assets; luckily, the recent rally has so far been fairly limited to Chinese equities and its proxies, thus leaving room for further upside opportunities, including oil, Industrials, & select U.S.-China-sensitive stocks,” wrote equities derivatives strategist Stefano Pascale. The picks from Barclays come on the heels of a big stimulus announcement out of China. Last week, the central bank announced a slew of measures to revamp growth and boost the struggling real estate market. However, Pascale warned that despite the strong upward move in Chinese equities on the news, the majority of the near-term gains are likely capped. Against this backdrop, the firm screened for companies with high sales exposure to China and low volatility. Here are some of the potential winners: Barclays named casino and resort operator Wynn Resorts among the beneficiaries of a China stimulus deal, with 48% sales exposure to China. Shares have risen nearly 8% in 2024.The consensus rating on the stock is a buy, according to LSEG data. Qualcomm is another winner, with 62% sales exposure to China and the second-highest among the stocks that made the cut. Shares of the chip stock have popped about 15% this year, benefitting from broader technology tailwinds. Some underperforming stocks could also benefit from China’s stimulus plan, including Albemarle . Shares of lithium provider — with 29% exposure to China — have shed more than a third of their value in 2024 due in part to slowing demand for electric vehicles and lower pricing due to oversupply. Merck and Western Digital also made the cut.